Results 1 to 10 of about 26,152 (254)
Arthritis and Rheumatology, 2021 To provide evidence‐based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN).
Sharon A Chung +2 more
exaly +3 more sources
Polyarteritis Nodosa: Old Disease, New Etiologies. [PDF]
Int J Mol Sci, 2023 Polyarteritis nodosa (PAN), also known as panarteritis nodosa, represents a form of necrotizing vasculitis that predominantly affects medium-sized vessels, although it is not restricted to them and can also involve smaller vessels.
Wolff L +4 more
europepmc +2 more sources
Cutaneous polyarteritis nodosa [PDF]
Anais Brasileiros de Dermatologia, 2015 Polyarteritis nodosa is a rare vasculitis in children characterized by necrotizing inflammation in small and medium size arteries. It is classified into systemic and cutaneous PAN according to the presence of systemic symptoms or visceral involvement. We
María Alejandra Matteoda +5 more
doaj +7 more sources
Cutaneous polyarteritis nodosa [PDF]
British Journal of Dermatology, 2002 Classic polyarteritis nodosa (PAN) is a segmentary leucocytoclastic vasculitis that affects small- and medium-sized arteries. In 1931, Lindberg (Acta Med Scand 1931; 76: 183-225) described the existence of a cutaneous variant of PAN, without visceral involvement and with a more favourable prognosis. We present four patients diagnosed with cutaneous PAN
España, A. (Agustín) +2 more
openaire +4 more sources
Case Report: A case of cutaneous polyarteritis nodosa in a child following a streptococcal infection [PDF]
Frontiers in PediatricsBackgroundPolyarteritis nodosa is a rare systemic necrotizing vasculitis that is often overlooked and misdiagnosed in clinical practice. Patients may exhibit fever, rash, myalgia, and further symptoms; in severe instances, this may result in damage to ...
Wei Cheng, Wei Yin, Fan Liu, Wen Yin
doaj +2 more sources
Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa [PDF]
Pediatric Rheumatology Online Journal, 2015 Objectives Definitive sample sizes for clinical trials in rare diseases are usually infeasible. Bayesian methodology can be used to maximise what is learnt from clinical trials in these circumstances.
Lisa V. Hampson +21 more
semanticscholar +3 more sources
Journal of Dermatology and Dermatologic Surgery, 2017 Cutaneous polyarteritis nodosa is a rare subtype of polyarteritis nodosa that lacks significant internal organ involvement. It has a relapsing remitting nature and usually is less responsive to conventional treatments.
Ibrahim A. Al-Homood +1 more
doaj +2 more sources
Case Reports in Pediatrics, 2016 Pediatric polyarteritis nodosa is rare systemic necrotizing arteritis involving small- and medium-sized muscular arteries characterized by aneurysmal dilatations involving the vessel wall.
Kae Watanabe +2 more
doaj +2 more sources
Polyarteritis nodosa presenting with severe upper gastrointestinal bleeding: a case report [PDF]
Journal of Medical Case ReportsBackground Polyarteritis nodosa is a relatively uncommon type of systemic necrotizing vasculitis that primarily affects medium-sized arteries. While gastrointestinal involvement is known in polyarteritis nodosa, heavy gastrointestinal bleeding due to ...
Xin-Yue Xiao +7 more
doaj +2 more sources
Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature [PDF]
Diagnostic Pathology, 2012 Angioimmunoblastic T-cell lymphoma is one of the most common subtypes of peripheral T-cell lymphoma (15-20% of all cases), accounting for approximately 1-2% of all non-Hodgkin lymphomas.
Ambrosio Maria +7 more
doaj +4 more sources